These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 8133075)
1. Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG. Shitara K; Fujiwara K; Igarashi S; Ohta S; Furuya A; Nakamura K; Koike M; Hanai N J Immunol Methods; 1994 Feb; 169(1):83-92. PubMed ID: 8133075 [TBL] [Abstract][Full Text] [Related]
2. Chimeric anti-ganglioside GM2 antibody with antitumor activity. Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257 [TBL] [Abstract][Full Text] [Related]
3. Recombinant antibodies against ganglioside expressed on tumor cells. Hanai N; Nakamura K; Shitara K Cancer Chemother Pharmacol; 2000; 46 Suppl():S13-7. PubMed ID: 10950141 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against camel (Camelus dromedarius) IgG, IgM and light chains. Azwai SM; Carter SD; Woldehiwet Z Vet Immunol Immunopathol; 1995 Mar; 45(1-2):175-84. PubMed ID: 7604534 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc). Sanai Y; Yamasaki M; Nagai Y Biochim Biophys Acta; 1988 Feb; 958(3):368-74. PubMed ID: 2449247 [TBL] [Abstract][Full Text] [Related]
6. Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine. Kitamura K; Livingston PO; Fortunato SR; Stockert E; Helling F; Ritter G; Oettgen HF; Old LJ Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2805-9. PubMed ID: 7708728 [TBL] [Abstract][Full Text] [Related]
7. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni. Ritter G; Fortunato SR; Cohen L; Noguchi Y; Bernard EM; Stockert E; Old LJ Int J Cancer; 1996 Apr; 66(2):184-90. PubMed ID: 8603809 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies. Ohta S; Igarashi S; Honda A; Sato S; Hanai N Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645 [TBL] [Abstract][Full Text] [Related]
9. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside. Livingston PO; Ritter G; Srivastava P; Padavan M; Calves MJ; Oettgen HF; Old LJ Cancer Res; 1989 Dec; 49(24 Pt 1):7045-50. PubMed ID: 2582446 [TBL] [Abstract][Full Text] [Related]
10. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen. Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797 [TBL] [Abstract][Full Text] [Related]
11. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2). Young WW; MacDonald EM; Nowinski RC; Hakomori SI J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581 [TBL] [Abstract][Full Text] [Related]
12. Generation and characterisation of murine monoclonal antibodies specific for cervine immunoglobulin light chain, IgM and IgG. Hibma M; Griffin JF Vet Immunol Immunopathol; 1992 Mar; 31(3-4):267-78. PubMed ID: 1589954 [TBL] [Abstract][Full Text] [Related]
13. Variations in the secretion of monoclonal antibodies by human-human hybridomas. Gaffar SA; Surh CD; Glassy MC Hybridoma; 1986; 5(2):93-105. PubMed ID: 3721525 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal equine IgM and IgG immunoglobulins. Wagner B; Radbruch A; Richards C; Leibold W Vet Immunol Immunopathol; 1995 Jul; 47(1-2):1-12. PubMed ID: 8533286 [TBL] [Abstract][Full Text] [Related]
15. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype. Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320 [TBL] [Abstract][Full Text] [Related]
17. Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study. López-Requena A; Rodríguez M; de Acosta CM; Moreno E; Puchades Y; González M; Talavera A; Valle A; Hernández T; Vázquez AM; Pérez R Mol Immunol; 2007 Feb; 44(5):1015-28. PubMed ID: 16620986 [TBL] [Abstract][Full Text] [Related]
18. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens. Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324 [No Abstract] [Full Text] [Related]
19. Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions. Reitan SK; Hannestad K Proc Natl Acad Sci U S A; 2002 May; 99(11):7588-93. PubMed ID: 12032327 [TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies. Kusano A; Ohta S; Shitara K; Hanai N Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]